RayzeBio Inc. Common Stoc...

NASDAQ: RYZB · Real-Time Price · USD
62.49
0.01 (0.02%)
At close: Feb 23, 2024, 10:00 PM

RayzeBio Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q2 2023 Q4 2022
Period Ending Sep 30, 2023 Jun 30, 2023 Dec 31, 2022
Cash & Equivalents
251.96M 33.21M 129.16M
Short-Term Investments
288.2M 223.74M 167.09M
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
347K 1.13M 347K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
4.82M 3.59M 3.79M
Total Current Assets
544.99M 260.55M 300.04M
Property-Plant & Equipment
58.18M 44.09M 24.39M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
58.53M 45.22M 24.74M
Total Assets
603.51M 305.76M 324.78M
Account Payables
2.24M 2.43M 2.62M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
1.27M 1.23M 1.14M
Other Current Liabilities
13.61M 11M 6.69M
Total Current Liabilities
17.11M 14.66M 10.46M
Long-Term Debt
8.46M 8.79M 9.43M
Other Long-Term Liabilities
2.62M 417.81M 416.19M
Total Long-Term Liabilities
11.08M 426.59M 425.61M
Total Liabilities
28.19M 441.25M 436.07M
Total Debt
9.72M 10.01M 10.57M
Common Stock
6K 3K 2K
Retained Earnings
-180.13M -160.73M -130.12M
Comprehensive Income
-386K -566K -553K
Shareholders Equity
575.32M -135.49M -111.29M
Total Investments
288.2M 223.74M 167.09M